AutoCRAT was introduced to attendees at EU-MSC2, a bi-annual event, organized by the Leiden University Medical Center in The Netherlands. The meeting assembles researchers, clinicians and cell product developers working within EU-sponsored research consortia, that focus on mesenchymal stromal cell (MSC) therapy for immune-related disorders and tissue regeneration. EU-MSC2, a much-anticipated event provides excellent opportunities for networking, exploring new funding opportunities and the dissemination of results contributing to MSC knowledge-sharing, research and development.
Prof Mary Murphy presented the final results of AUTOSTEM (grant 667932), the precursor EU Horizon 2020-funded project of AutoCRAT. Mary’s talk kicked off the September 5, 2019 meeting and was entitled: A fully closed system: from donor cell procurement to patient administration.
The comprehensive meeting report prepared by Katerina Apelt, Brigitte Wieles and Melissa van Pel of LUMC was published on April 29th, 2020, by the Regenerative Medicine Network. Read their findings here.
